Irreversible myocardial injury attenuates the benefits of sacubitril/valsartan in heart failure patients. Choi HM, Hwang IC, Choi HJ, Yoon YE, et al. Int J Cardiol 2023 Nov 27:131611. doi: 10.1016/j.ijcard.2023.131611.

Read + Share

Amedeo Smart

Independent Medical Education

Choi HM, Hwang IC, Choi HJ, Yoon YE, et al. Irreversible myocardial injury attenuates the benefits of sacubitril/valsartan in heart failure patients. Int J Cardiol 2023 Nov 27:131611. doi: 10.1016/j.ijcard.2023.131611.
PMID: 38030041